Jun 30, 2012

United Therapeutics Q2 2012 Earnings Report

Total Revenue
$226M
Previous year: $181M
+24.9%
EPS
$2.37
Previous year: $1.28
+85.2%
Gross Profit
$196M
Previous year: $163M
+20.5%
Cash and Equivalents
$157M
Previous year: $321M
-51.1%
Free Cash Flow
$43.7M
Previous year: $52M
-15.9%
Total Assets
$1.56B
Previous year: $1.58B
-1.4%

United Therapeutics

United Therapeutics